# Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver

> **NCT00742911** · PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 21 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Disulfiram
- **DRUG:** Copper Gluconate

## Key facts

- **NCT ID:** NCT00742911
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742911, "Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00742911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*